Hematology
6 years
Dr. Priyanka Vasudeo Moule is a Haematology specialist associated with Fortis Hospital, Mulund, Mumbai. She is listed as an Associate Consultant in Hemato-Oncology and Bone Marrow Transplantation, a field concerned with disorders affecting blood cells, blood-forming tissues and the bone marrow.
Her verified educational qualifications include MBBS and DNB in Pathology. Her hospital profile records the completion years as 2014 and 2018, respectively. Additional professional information lists training in Clinical Haematology, which should be confirmed directly before publication.
Haematology involves the evaluation of conditions affecting red blood cells, white blood cells, platelets and the blood-clotting system. Clinical assessment may involve reviewing blood counts, laboratory investigations, medical history and other diagnostic findings to identify the underlying cause of abnormalities.
Hemato-oncology focuses on blood-related cancers, including leukaemia, lymphoma and multiple myeloma. Assessment and treatment planning can involve specialist diagnostic procedures, medications and multidisciplinary care based on the diagnosis, disease classification and individual patient circumstances.
Bone marrow transplantation is an important treatment option for certain haematological disorders. Patients requiring transplant evaluation generally undergo detailed medical assessment to determine the suitability, expected benefits and potential risks of the available treatment approaches.
Patients seeking specialist haematology evaluation or consultation related to blood disorders in Mulund, Mumbai, may contact Fortis Hospital to enquire about Dr. Priyanka Vasudeo Moule's consultation availability and clinical services.
Anaemia occurs when the blood has insufficient healthy red blood cells or haemoglobin to transport oxygen effectively. Evaluation may involve a complete blood count, iron studies, vitamin levels and other investigations. Treatment depends on identifying the underlying cause of the anaemia.
Iron-deficiency anaemia develops when the body lacks enough iron to produce adequate haemoglobin. Symptoms may include fatigue, weakness and shortness of breath. Management focuses on identifying the reason for iron deficiency and providing appropriate iron replacement or other necessary treatment.
Vitamin B12 deficiency may impair normal red blood cell production and can sometimes cause neurological symptoms. Diagnosis involves reviewing blood counts, vitamin levels and possible causes of deficiency. Treatment commonly includes oral or injectable vitamin replacement based on individual clinical circumstances.
Thalassaemia is an inherited blood disorder affecting haemoglobin production. Disease severity varies, and some patients require regular blood transfusions, monitoring of iron levels or other specialist treatment. Management depends on the type of thalassaemia and the patient's clinical needs.
Sickle cell disease is an inherited disorder in which red blood cells can become abnormally shaped, potentially causing anaemia, painful episodes and organ complications. Management may include preventive care, medication, transfusion support and monitoring for complications under specialist supervision.
Thrombocytopenia refers to a lower-than-normal platelet count. It may result from immune disorders, medication effects, infections or bone marrow conditions. Evaluation aims to identify the underlying cause and determine whether observation, medication or other targeted treatment is appropriate.
Haemophilia and other bleeding disorders affect the body's ability to form stable blood clots. Patients may experience prolonged bleeding, easy bruising or internal bleeding. Diagnosis involves specialised coagulation testing, and treatment may include clotting factor replacement or other appropriate therapies.
Leukaemia refers to cancers that affect blood-forming cells, commonly involving the bone marrow and circulating blood. Evaluation may require blood tests, bone marrow examination, immunophenotyping and molecular investigations. Treatment depends on the specific leukaemia subtype and the patient's condition.
Lymphoma is a group of cancers affecting lymphocytes, which are cells involved in the immune system. Assessment may include tissue biopsy, imaging and specialised laboratory testing. Treatment options differ according to lymphoma subtype, disease stage and the patient's overall health.
Multiple myeloma is a blood cancer involving abnormal plasma cells within the bone marrow. It can affect bones, kidneys and blood cell production. Diagnosis may require blood tests, urine studies, imaging and bone marrow assessment, followed by individualised treatment planning.
Bone marrow or haematopoietic stem cell transplantation may be considered for selected blood cancers and other haematological disorders. Assessment examines the underlying disease, transplant eligibility, donor availability when relevant, and the potential benefits and risks of transplantation.
Myelodysplastic syndromes are bone marrow disorders associated with abnormal blood cell production. Patients may develop anaemia, infections or bleeding complications. Evaluation usually involves blood counts, bone marrow examination and specialised tests to classify the disease and guide treatment decisions.
MBBS, DNB (Pathology)
Haematology consultations, anaemia evaluation, iron-deficiency anaemia assessment, vitamin B12 deficiency anaemia evaluation, haemolytic anaemia assessment, thalassaemia management, sickle cell disease evaluation, haemophilia assessment, bleeding disorder evaluation, clotting disorder assessment, thrombocytopenia management, platelet disorder evaluation, neutropenia assessment, leukaemia evaluation, lymphoma evaluation, multiple myeloma assessment, myelodysplastic syndrome evaluation, myeloproliferative disorder evaluation, hemato-oncology consultations, bone marrow transplantation assessment.
Genuine patient experiences and treatment feedback.
Quick answers to common questions about Dr. Priyanka Vasudeo Moule
She is associated with haematology and hemato-oncology, including the field of bone marrow transplantation.
Fortis confirms MBBS and DNB (Pathology). A supplementary medical profile additionally lists DNB (Clinical Haematology), which should be independently confirmed.
Fortis Healthcare lists six years of experience.
Haematology includes disorders involving red blood cells, white blood cells, platelets, clotting and bone marrow function.
Yes. Hemato-oncology deals with blood-related cancers such as leukaemia, lymphoma and multiple myeloma. Her specific treatment responsibilities should be confirmed.
Contact us for personalized help or to schedule an appointment.